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Axonal transport is essential for neuronal function,
and defects in transport are associated with multiple
neurodegenerative diseases. Aberrant cyclin-depen-
dent kinase 5 (CDK5) activity, driven by the stress-
induced activator p25, also is observed in these
diseases. Here we show that elevated CDK5 activity
increases the frequency of nonprocessive events for
a range of organelles, including lysosomes, autopha-
gosomes, mitochondria, and signaling endosomes.
Transport disruption induced by aberrant CDK5 acti-
vation depends on the Lis1/Ndel1 complex, which
directly regulates dynein activity. CDK5 phosphory-
lation of Ndel1 favors a high affinity Lis1/Ndel/dynein
complex that blocks the ATP-dependent release of
dynein from microtubules, inhibiting processive
motility of dynein-driven cargo. Similar transport de-
fects observed in neurons from a mouse model of
amyotrophic lateral sclerosis are rescued by CDK5
inhibition. Together, these studies identify CDK5
as a Lis1/Ndel1-dependent regulator of transport in
stressed neurons, and suggest that dysregulated
CDK5 activity contributes to the transport deficits
observed during neurodegeneration.INTRODUCTION
Axonal transport is essential to maintain neuronal viability, yet
themolecular mechanisms that regulate transport are not yet un-
derstood. The coordinated activities of anterograde-directed
kinesins and retrograde-directed dynein motors drive transport
in neurons. Motor activity is regulated by multiple mechanisms,
leading to efficient long-distance transport and the specific tar-
geting of organelles to appropriate locations (Fu and Holzbaur,
2014; Hancock, 2014; Maday et al., 2014).
One kinase proposed to regulate axonal transport is cyclin-
dependent kinase 5 (CDK5) (Goodwin et al., 2012; Ou et al.,
2010; Pandey and Smith, 2011). While most cyclin-dependent
kinases regulate the cell cycle (Dhariwala and Rajadhyaksha,
2008), CDK5 expression is limited to post-mitotic cells including
neurons (Tsai et al., 1993). The primary activator of neuronal462 Cell Reports 12, 462–473, July 21, 2015 ª2015 The AuthorsCDK5 is p35. The CDK5/p35 complex is both temporally and
spatially regulated; the active complex remains bound to the
plasma membrane and is inactivated within 20 min via CDK5-
dependent phosphorylation of p35 (Figure 1A), which targets
p35 for ubiquitination and proteosomal degradation (Dhavan
and Tsai, 2001; Kusakawa et al., 2000; Patrick et al., 1998).
The CDK5/p35 complex plays an important role in neuronal
development and migration, but its function in mature neurons
is less well understood (Modi et al., 2012; Su and Tsai, 2011).
Multiple studies have implicated CDK5 in the regulation of
vesicle and organelle trafficking, with conflicting conclusions.
In C. elegans, CDK5 regulates axodendritic sorting (Goodwin
et al., 2012; Ou et al., 2010). In mice, CDK5 has been proposed
to regulate the anterograde transport of organelles through a
pathway involving glycogen synthase kinase 3 and kinesin
(Morel et al., 2010; Morfini et al., 2004). Alternatively, CDK5
has been proposed to enhance the bidirectional transport of ly-
sosomes via a mechanism involving nuclear distribution protein
nudE-like 1 (Ndel1), Lis1, and dynein (Pandey and Smith, 2011).
Ndel1 and Lis1 have been studied extensively in the context of
lissencephaly; they form a complex that binds to and regulates
cytoplasmic dynein (Huang et al., 2012; Wynshaw-Boris,
2007). Ndel1 is a known CDK5 phosphorylation target, suggest-
ing a potential mechanism for the effects of CDK5 on dynein-
mediated axonal transport.
Under conditions of cellular stress, including oxidative stress,
ischemia, mitochondrial dysfunction, inflammation, or disease,
CDK5 activity becomes misregulated. Calcium influx activates
calpain, which cleaves p35 to a membrane-bound p10 subunit
and a cytosolic p25 subunit (Figure 1A; Su and Tsai, 2011; Zhang
et al., 2012). The p25 subunit retains the activation site for CDK5,
but not the phosphorylation site necessary for ubiquitination and
subsequent degradation. Thus, the p25/CDK5 complex displays
sustained activation that is both temporally and spatially deregu-
lated (Dhariwala and Rajadhyaksha, 2008).
The deregulation of CDK5 in stressed neurons suggests that
aberrant CDK5 activity may contribute to neurodegeneration
(Dhariwala and Rajadhyaksha, 2008). Both abnormal cellular
localization and hyperactivation of CDK5 has been observed
in neurons of patients with amyotrophic lateral sclerosis (ALS).
This rise in CDK5 activity is accompanied by the accumulation
of cargo in the cell body and proximal axon of both motor and
sensory neurons in mouse models of ALS (Cozzolino et al.,
2012; Shukla et al., 2012). Diverse cargo, including lysosomes,
autophagosomes, mitochondria, and signaling molecules such
Figure 1. Activation, but Not Inhibition, of
CDK5 Regulates Transport of Rab7- and
LAMP1-Positive Lysosomes
(A) When bound to the endogenous membrane-
bound activator p35, CDK5 activity is temporally
and spatially restricted. When bound to the stress-
induced activator p25, CDK5 activity is prolonged
and untethered from the membrane, leading to
both temporal and spatial deregulation.
(B) Kymographs of lysosomal motion in DRG
neurites expressing Rab7-GFP. Representative
runs are highlighted to the right of each kymo-
graph as follows: green, anterograde; red, retro-
grade; and yellow, stationary. White arrows
indicate individual pauses and reversals during
right-most retrograde run in each.
(C) While inhibition of CDK5 had no effect on the
nonprocessive motion of Rab7-tagged lyso-
somes, activation of CDK5 by p25 decreased
processivity.
(D) Kymographs from DRG neurites transfected
with LAMP1-RFP. Representative runs are high-
lighted to the right of each kymograph.
(E) Inhibition of CDK5 activity using multiple
approaches, including expression of a dominant-
negative construct (dnCDK5), depletion of endoge-
nous CDK5 by siRNA, and treatment with the CDK5
inhibitor roscovitine, had no effect on lysosomal
transport. In contrast, increasing CDK5 activity via
the expression of p25 significantly increased non-
processive events. The effects of p25 were blocked
by expression of dnCDK5 or depletion of CDK5.
Scale bars represent 10 s and 10 mm. Graphs
indicate means ± SEM; n = 15 neurons from at
least three experiments. Differences between
conditions were analyzed by one-way ANOVA
with Tukey’s post hoc test; ***p < 0.001.as neurotrophic factors and receptors, exhibits altered axonal
trafficking in the disease state (Cozzolino et al., 2012; Magrane´
et al., 2014; Perlson et al., 2009).
Herewe investigate the role of CDK5 in the regulation of axonal
transport. We find that CDK5 activity is not required to maintain
constitutive transport of multiple cargos. However, elevated
CDK5 activity leads to misregulation of all cargos examined.
Activated CDK5 operates via the Lis1/Ndel1/dynein pathway,
as the effects can be blocked by mutations that prevent the
CDK5-dependent phosphorylation of Ndel1 or mutations in
Lis1 that inhibit binding to dynein. Finally, we establish that the
transport deficits observed in a mouse model of ALS mirror the
effects induced by activation of CDK5 and can be rescued by
CDK5 inhibition. Together, these observations indicate that
stress-induced activation of CDK5 may contribute to the disrup-
tion of transport observed in ALS and other neurodegenerative
diseases, such as Alzheimer’s and Parkinson’s, that exhibit dys-
regulated CDK5 activity.
RESULTS
CDK5 Activation, but Not Inhibition, Affects the Axonal
Transport of Late Endosomes and Lysosomes
CDK5 has been reported to regulate the constitutive transport of
lysotracker-positive acidic organelles (Pandey and Smith, 2011).To further investigate this possibility, we used live-cell imaging
to examine the effects of changes in CDK5 activity on themotility
of Rab7- and LAMP1-positive vesicles in primary dorsal root
ganglia (DRG) neurons, awell-establishedmodel of axonal trans-
port (Maday et al., 2012; Moughamian and Holzbaur, 2012; Perl-
son et al., 2009).
In control neurons, Rab7-positive late endosomes and lyso-
somes move bidirectionally along the axon, with a bias toward
retrograde motility (Figure 1B). Expression of a kinase-dead
dominant-negative CDK5 (dnCDK5) that binds to and seques-
ters p35 (Nikolic et al., 1996) did not significantly affect transport
velocities (Figure S1), the ratio of motile to stationary organelles,
or the number of pauses and reversals observed during proces-
sive motility. Expression of the CDK5 activator p25 also did not
significantly affect the percentage of Rab7-positive lysosomes
demonstrating stationary, anterograde, or retrograde motility
(Table S1). However, expression of p25 led to a significant in-
crease in the frequency of nonprocessive events interrupting
rapidly moving organelles. This disruption was observed in car-
gos moving in both the anterograde and retrograde directions
(Figures 1C and S2A).
Next we examined LAMP1-RFP, a well-characterized reporter
for the motility of the late endosomal/lysosomal compartment
(Moughamian and Holzbaur, 2012). Similar to our observations
with Rab7-GFP, minimal changes in the bidirectional motility ofCell Reports 12, 462–473, July 21, 2015 ª2015 The Authors 463
Figure 2. CDK5 Activation, but Not Inhibition, Disrupts Mitochondrial Transport
(A) Kymographs of DsRed2-mito-labeled mitochondria in DRG neurites. Representative runs are highlighted below each kymograph as follows: green, anter-
ograde; red, retrograde; and yellow, stationary. Scale bars represent 30 s and 10 mm.
(B) Long tubular mitochondria were found along the neurites of DRG neurons in the control and dnCDK5 conditions, but they fragmented into smaller pieces upon
the expression of p25.
(C) The activation of CDK5 by p25 decreased the size of mitochondria, while inhibition of CDK5 had no effect on mitochondrial length.
(D) The activation of CDK5 increased the density of mitochondria along the axon. Co-expression of p25 with either dnCDK5 or siRNA against CDK5 partially
diminished the increase in mitochondrial density.
(E) The activation of CDK5 increased the nonprocessive motion of mitochondria. The effects of p25 were blocked by the inhibition of CDK5.
Graphs depict means ± SEM; nR 12 neurons from at least three experiments. Values that differ significantly (one-way ANOVA with Tukey’s post hoc test) are
noted on graphs (*p < 0.05, **p < 0.01, ***p < 0.001).LAMP1-positive organelles were observed upon expression of
dnCDK5 (Figure 1D). We used two additional approaches to
inhibit CDK5 activity as follows: (1) depletion of 90% of endoge-
nous CDK5 using small interfering RNA (siRNA) (Figures S1C
and S1D), and (2) pharmacological inhibition with roscovitine
(Meijer et al., 1997; Zheng et al., 2007). Neither approach led to
a measurable effect on axonal transport, suggesting that CDK5
activity is not required to regulate the constitutive transport of
late endosomes and lysosomes along the axon.
In contrast, activation of CDK5 by p25 led to a significant in-
crease in the frequency of nonprocessive events during directed
transport of LAMP1-positive organelles, similar to the changes
observed in Rab7-positive organelles. To test the specificity
of this effect, we co-expressed p25 and dnCDK5 and found464 Cell Reports 12, 462–473, July 21, 2015 ª2015 The Authorsthat the p25-induced increase in nonprocessive motility was
completely blocked by CDK5 inhibition (Figures 1E and S3B).
Similarly, depletion of CDK5 using siRNA blocked the alteration
in motility induced by the expression of p25, supporting the
conclusion that the effects of p25 are mediated by the hyperac-
tivation of CDK5.
CDK5 Activation Disrupts Mitochondria Transport
Next, we examined mitochondrial motility using the marker
DsRed2-mito, which labels both tubular and vesicular mitochon-
dria in the axon (Figure 2B). Robust bidirectional motility of
large and small mitochondria was observed (Figure 2A; Table
S1). Similar to our observations for late endosomes/lysosomes,
expression of dnCDK5, depletion of endogenous CDK5 by
Figure 3. Activation of CDK5 Decreases the Motility of Retrograde-Directed Cargos
(A) Kymographs of autophagosomes in DRG neurites from mice expressing GFP-LC3. Representative runs are highlighted below each kymograph as follows:
green, anterograde; red, retrograde; and yellow, stationary.
(B) Ensemble speeds of autophagosomes decreased with increased CDK5 activity.
(C) The activation of CDK5 increased the nonprocessive motion of retrograde-directed LC3 cargo.
(D) Kymographs of TrkB motion in DRG neurites transfected with TrkB-mRFP. Representative runs are highlighted to the right of each kymograph.
(E) Speed of actively transported TrkB cargo decreased with increased CDK5.
(F) The inhibition of CDK5 activity by dnCDK5 or the chemical inhibitor roscovitine had no effect on processivity of TrkB. In contrast, activation of CDK5 increased
nonprocessive motion of TrkB cargo.
Scale bars represent 10 s and 10 mm. Graphs depict means ± SEM; nR 15 neurons from at least three experiments. Values that differ significantly (one-way
ANOVA with Tukey’s post hoc test) are noted on graphs (*p < 0.05, **p < 0.01, ***p < 0.001).siRNA, or chemical inhibition had no effect on mitochondrial
motility. However, p25-induced activation of CDK5 increased
the number of nonprocessive events exhibited by actively
moving mitochondria. Again, the increase in oscillatory motion
induced by p25 expression was reduced by co-expression of
dnCDK5, depletion of CDK5 by siRNA, or treatment with the
chemical inhibitor roscovitine (Figures 2D and S2B), indicating
the specificity of the observed effects.
p25 expression also resulted in increased fragmentation of
mitochondria (Figures 2B and 2C) as well as an increase
in mitochondrial density along the axon, as previously noted
(Meuer et al., 2007). Neurons exposed to diminished levels of
CDK5 activity (dnCDK5, siRNA to CDK5, roscovitine) did not
exhibit changes in mitochondrial density or fragmentation (Fig-ure 2E). While co-expression of dnCDK5 or depletion of endog-
enous CDK5 by siRNA was not sufficient to block these effects,
roscovitine treatment was sufficient to rescue the effects on
mitochondrial density induced by p25.
Perturbation of CDK5 Activity Strongly Disrupts
Transport of Retrograde-Biased Cargos
Both lysosomes and mitochondria are bidirectional cargo; thus,
their motility results from the coordinated activities of both
dynein and kinesins (Maday et al., 2014). To more directly
examine the effects of CDK5 on dynein-driven transport, we
imaged GFP-LC3-positive autophagosomes (Klionsky et al.,
2012; Maday et al., 2012), which move in a robust retrograde
manner along the axon (Figure 3A). Autophagosome motilityCell Reports 12, 462–473, July 21, 2015 ª2015 The Authors 465
was decreased with any modulation of CDK5 activity (Table S1),
although p25 expression induced the most pronounced effects.
The decrease in motility and the increase in oscillatory events led
to a striking decrease in the ensemble speed of retrograde-
directed autophagosomes induced by changes in CDK5 expres-
sion (Figure 3B).
The number of pauses and reversals during autophagosome
transport was measured in neurons overexpressing either
dnCDK5 or p25. Autophagosomes displayed an increase in
nonprocessive events when CDK5 activity was increased via
p25 expression (Figure 3C). Thus, autophagosomes, lysosomes,
and mitochondria all exhibited increased pauses and switches
upon CDK5 activation by p25. In contrast, reduction of CDK5
activity had no significant effect on the motility of lysosomes
or mitochondria, but did reduce the ensemble speed of
autophagosomes.
TrkB, the receptor for neurotrophic factor BDNF, moves bidi-
rectionally in neurons, with a bias toward retrograde motility
(Table S1). Reduction of CDK5 activity either by the expression
of dnCDK5 or roscovitine treatment had no effect on the trans-
port of mRFP-TrkB-positive endosomes. In contrast, p25-
induced activation of CDK5 led to oscillatory movement of
TrkB, similar to the effects observed for other cargos (Figures
3D and 3F); we also noted a decrease in the peak velocity of
TrkB transport (Figure 3E).
Active CDK5 Promotes Dynein Binding to Microtubules
Together, these observations indicate that increased CDK5 ac-
tivity affects the transport of multiple axonal cargos, with the
most striking effects observed for retrograde-directed cargos.
This suggests that the retrogrademotor dyneinmay be the target
of CDK5 activity. The binding of ATP to dynein induces the
release of the motor from the microtubule by inducing a confor-
mational change in dynein’s linker domain; the dynein-binding
protein Lis1 modulates this conformational change, enhancing
the strongly bound state (Huang et al., 2012). Ndel1, a known
phosphorylation target of CDK5, enhances the binding of Lis1
to dynein (McKenney et al., 2010; Niethammer et al., 2000).
We hypothesized that the CDK5-dependent phosphorylation
of Ndel1 would promote the formation of a more stable Lis1/N-
del1/dynein complex and thus induce a sustained interaction
of dynein with the microtubule. For organelles trafficking along
the axon, this would be predicted to lead to an increase in
pauses and reversals upon activation of CDK5 by p25.
To determine whether the binding of dynein to microtubules is
enhanced by activated CDK5, a microtubule-binding assay was
performed using HeLa cell lysates expressing CDK5 or co-ex-
pressing CDK5 and p25 (Figure 4A). Co-expression of CDK5
and p25 significantly enhanced the binding of dynein to microtu-
bules in the presence of ATP as compared to CDK5 alone
(Figure 4B).
A high-resolution in vitro assay was used to determine if CDK5
affects dynein motility by favoring increased attachment to the
microtubule. Lysates from HeLa cells stably expressing GFP-
tagged dynein heavy chain (DHC-GFP) (Kiyomitsu and Cheese-
man, 2012) and transfected with CDK5, or both CDK5 and p25,
were depleted of ATP and perfused into a flow chamber with
rhodamine-tagged microtubules fixed to glass coverslips (Fig-466 Cell Reports 12, 462–473, July 21, 2015 ª2015 The Authorsure 4C). Total internal reflection fluorescence (TIRF) microscopy
was used to image individual dynein motors bound to microtu-
bules. Images of the same microtubules were captured before
and after the addition of 10 mM Mg-ATP (Figure 4D). Following
the addition of ATP, we observed a release of dynein from the
microtubule in lysates expressing CDK5. In contrast, the addition
of ATP to lysates expressing CDK5 and p25 did not significantly
alter dynein binding from pre-ATP levels (Figures 4E and 4F).
Together these results demonstrate that activated CDK5 en-
hances the binding of dynein to microtubules, even in the pres-
ence of saturating ATP.
CDK5 Controls Dynein Motion via a Lis1/Ndel1-
Dependent Mechanism
Our in vitro experiments indicate that activatedCDK5 is sufficient
to induce sustained binding of dynein to microtubules, but CDK5
does not directly phosphorylate dynein (Hallows et al., 2003).
Onewell-characterized target of CDK5-dependent phosphoryla-
tion is Ndel1 (Pandey and Smith, 2011). A 2:2 complex of Lis1
and Ndel1 binds the dynein motor (Figure 5A) and phosphoryla-
tion of Ndel1 enhances this binding (Zy1kiewicz et al., 2011).
Ndel1 contains five CDK5 phosphorylation sites as follows:
S198, T219, S231, S242, and T245 (Figure 5B; Niethammer
et al., 2000); mutating these five residues to alanine (Ndel1
mut) blocks the CDK5-dependent phosphorylation of Ndel1
(Hebbar et al., 2008).
To determine whether phosphorylation of Ndel1 by CDK5 is
required to induce the observed effects on dyneinmotility, we ex-
pressed either wild-type Ndel1 or the unphosphorylatable Ndel1
mutant along with LAMP1-RFP. Overexpression of either Ndel1
construct didnot affect the speedor extent ofmotility; co-expres-
sionof dnCDK5alsodidnot disrupt lysosomalmotility in thepres-
ence of either Ndel1 construct (Figure 5D, middle). While p25
expression increased the number of oscillatory events interrupt-
ing the transport of lysosomes in thepresenceofwild-typeNdel1,
expression of unphosphorylatable Ndel1 significantly reduced
the defects in lysosomal motility caused by p25 expression (Fig-
ure 5E), supporting our hypothesis that phosphorylation of Ndel1
regulates CDK5-dependent changes in transport.
Next, we asked whether the p25-induced changes in lyso-
somal transport were Lis1 dependent. Lis1 contains two regions
essential for binding dynein. Mutation of K147 (Figure 5C) dis-
rupts the binding of Lis1 to dynein, but not to Ndel1 (Mesngon
et al., 2006). We found that expression of the Lis1 K147A mutant
reduced both anterograde and retrograde transport of lyso-
somes, regardless of the activity level of CDK5 (Figure 5D, far
right). This reduction was accompanied by an increase in sta-
tionary lysosomes but did not change lysosomal density. The
same changes were not observed with overexpression of wild-
type Lis1 (Figure S4). Despite the overall decrease in motility,
some lysosomes continued to exhibit robust movement in the
presence of the Lis1 mutant, allowing for analysis of pauses
and directional switches. Among the motile lysosomes, expres-
sion of the Lis1 mutant reduced the magnitude of the p25-
induced increase in nonprocessive events. Although LAMP1-
positive lysosomes exhibited a slight increase in the number of
nonprocessive events when p25 was expressed in the presence
of Lis1 K147A, this increase was minimal in comparison to the
Figure 4. Activated CDK5 Enhances Bind-
ing of Dynein to Microtubules In Vitro
(A) Extracts of HeLa cells expressing CDK5 or
CDK5 and p25 were exposed to 0, 5, or 10 mM
taxol-stabilized microtubules in the presence of
10 mM MgATP. Microtubule pellets were probed
for the binding of dynein intermediate chain (DIC).
(B) The addition of p25 increased dynein binding
to microtubules relative to CDK5 alone (means ±
SEM; n = 4 experiments).
(C) Schematic of the TIRF assay used to assess
dynein binding to the microtubule. HeLa cells
expressing DHC-GFP and endogenous levels of
Lis1 and Ndel1 were transfected with CDK5
or CDK5 and p25. Lysates from transfected
cells were perfused into a flow chamber with
rhodamine-tagged microtubules fixed to a glass
coverslip in the presence of hexokinase and
glucose to induce the rigor-bound state of
dynein. ATP was then added to the chambers
to induce the release of dynein from the
microtubule.
(D) TIRF images of a microtubule (top) and
attached dynein motors. Depletion of ATP
(hexokinase/glucose) caused decoration of mi-
crotubules with rigor-bound dynein (middle).
Addition of 10 mM MgATP in the absence of
activated CDK5 induced dynein release from the
microtubule (bottom left). In the presence of
activated CDK5, ATP-induced dissociation of
dynein from the microtubules was significantly
inhibited (bottom right).
(E) The addition of ATP induced the release of
dynein from microtubules in the presence of
inactive CDK5. Individual lines on the graph indi-
cate the change in dynein binding along a single
microtubule before (ATP) to after (+ATP) the
addition of 10 mM ATP. Data from 54 microtu-
bules and three experiments.
(F) The mean percentage of microtubule decorated by dynein decreased significantly when CDK5 was inactive, but not when active CDK5 was present (means;
nR 108 microtubules from seven chambers over three experiments). *p < 0.05, ***p < 0.001, n.s. indicates p > 0.05 (two-way ANOVAwith Tukey’s post hoc test).increase observed upon expression of p25 in the absence of the
Lis1 mutant (Figure 5F).
Previous work has shown that depletion of Lis1 causes
dramatic inhibition of lysosomal motility (Moughamian et al.,
2013), consistent with our finding that decreasing the affinity of
Lis1 for dynein reduced the number of anterograde- and retro-
grade-directed lysosomes (Figure 5G). Co-expression of the
dnCDK5 construct with mutant Lis1 resulted in the strongest
reduction in motility.
We also examined the effects of the Ndel1 mutant on auto-
phagosome transport, as the pronounced retrograde motion of
these organelles is dynein mediated (Maday et al., 2012). As
observed for lysosomes, GFP-LC3-labeled autophagosomes
displayed minimal changes in transport when either wild-type
or unphosphorylatable Ndel1 was expressed, at either unmodi-
fied or diminished levels of CDK5 activity (Figure 5H). Hyperacti-
vation of CDK5 by p25 led to a significant disruption of transport,
as observed by an increase in oscillatory events when wild-type
Ndel1 was overexpressed. However, expression of the mutant
form of Ndel1 was sufficient to block the p25-induced disruption
of autophagosome transport (Figures 5H and 5I).Autophagosomes, like lysosomes,displayeddiminishedoverall
transport in the presence of mutant Lis1, independent of any per-
turbations in CDK5 activity (Figures 5H and 5K). This observation
is consistent with a key role for Lis1 in dynein-mediated organelle
transport (Moughamian et al., 2013).However,wedidnot observe
a p25-induced increase in nonprocessive events in the fewmotile
puncta in the presence of mutant Lis1 (Figure 5J), supporting
the model that both Ndel1 and Lis1 are necessary downstream
effectors of CDK5/p25-induced nonprocessive motility.
SOD1G93A Mice Exhibit Dysregulated CDK5 Activity
Next, we sought to investigate a possible role for elevated CDK5
activity in driving the pathogenic changes in axonal transport
observed inmodelsofALSusing thewell-characterizedSOD1G93A
mouse. Elevated p25 expression and increased CDK5 activity
have been identified previously in the SOD1G37R mouse line
(Nguyen et al., 2001). To determine whether there is a similar acti-
vation of CDK5 in the SOD1G93A mouse, high-speed supernatant
fractions from spinal cords of 90- to 100-day-old SOD1G93A mice
and wild-type littermate controls were probed for the expression
of p35 and p25 using an antibody that recognizes both proteinsCell Reports 12, 462–473, July 21, 2015 ª2015 The Authors 467
Figure 5. Nonprocessive Motion of Degradative Cargo Induced by CDK5 Activation Depends on a Lis1/Ndel1/Dynein Mechanism
(A) Phosphorylated Ndel1 enhances Lis1 binding to dynein (Zy1kiewicz et al., 2011).
(B) Ndel1 contains five CDK5 phosphorylation sites. All five sites were mutated to Niethammer et al. (2000). Ndel1 also contains two dynein-binding regions and a
Lis1-binding region, as well as a coiled-coil domain and an a-helical domain.
(legend continued on next page)
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(Figure 6A). Quantitative analysis revealed a greater than 2-fold in-
crease in the p25/p35 ratio in the high-speed fraction from spinal
cord lysates fromSOD1G93Amice (Figure 6C), indicatingactivation
of CDK5 in this model. We also probed spinal cord lysates from
SOD1G93Amice andwild-type littermates with a phospho-specific
antibody to the T219 residue of Ndel1 (Figure 6B). Animals ex-
pressing mutant SOD1 exhibited almost double the level of phos-
phorylated Ndel1 compared to wild-type animals (Figure 6D).
Inhibition of CDK5 Rescues Disrupted TrkB Transport in
SOD1G93A Neurons
Defects in the retrograde transport of neurotrophic factors have
been proposed to contribute to the neuronal death characteristic
of ALS (Henriques et al., 2010). Processive motility of signaling
endosomes in neurons from SOD1G93A mice was shown to be
disrupted by frequent pauses and switches (Perlson et al.,
2009); in vivo analysis of transport in this model also showed
enhanced pausing of cargos along the axon (Bilsland et al.,
2010). The similarity of these observations to the nonprocessive
motility induced by p25 expression led us to ask whether the hy-
peractivation of CDK5 might contribute to the observed deficits
in axonal transport.
We assessed the effects of CDK5 inhibition on signaling endo-
some motility in DRG neurons cultured from 90- to 100-day-old
SOD1G93A mice. We observed an increase in the oscillatory mo-
tion of mRFP-tagged TrkB when compared to age-matched
controls (Figure 6E). Importantly, the oscillatorymotion observed
in SOD1G93A neurons was diminished in the presence of the
CDK5 inhibitor roscovitine, suggesting that increased CDK5 ac-
tivity was responsible for the abnormal motility (Figure 6F). TrkB
was transported more slowly in neurons expressing mutant
SOD1; this effect also was rescued by roscovitine treatment (Fig-
ure 6G). Parallel experiments using dnCDK5 to inhibit CDK5
activity did not completely restore motility, likely due to lower
expression levels of the transfected construct in SOD1G93A
neurons (data not shown). However, our observations with ro-
scovitine suggest that hyperactive CDK5 contributes to the
disruption in transport observed in this ALS model, and that
CDK5 inhibition can mitigate the effects of mutant SOD1 on
axonal transport.(C) Lis1 contains a Lis-homology domain (LH) for dimerization, as well as a co
A mutation in K147 disrupts binding to dynein (Mesngon et al., 2006).
(D) Kymographs of lysosomal motion in neurons transfected with wild-type Ndel
cannot bind dynein (Mesngon et al., 2006). Lysosomes were labeled with LAMP
(E) The increase in nonprocessive events induced by p25 was blocked by the ex
with wild-type Ndel1; horizontal stripes indicate transfection with unphosphoryla
(F) The effects of p25 expression on processivity of lysosomal transport were les
(G) Expression of the Lis1 K147Amutation reduced the number of anterograde- an
(total run lengths <10 mm) lysosomes compared to overexpression of a Lis1 wild
(H) Kymographs of autophagosomes labeled with LC3-GFP in the presence of w
(I) The number of nonprocessive events in autophagosome transport was reduced
with wild-type Ndel1; horizontal stripes indicate transfection with unphosphoryla
(J) Variations in CDK5 activity had no effect on autophagosome transport in cells
(K) Expression of the Lis1 K147A mutation reduced the number of retrograde-d
phagosomes.
Scale bars represent 10 s and 10 mm. Graphs depict means ± SEM; nR 16 neu
ANOVAwith Tukey’s post hoc test, E, F, I, and J, or two-way ANOVAwith Tukey’s
n.s. or no asterisks indicates p > 0.05.DISCUSSION
Here we found that inhibition of CDK5 does not significantly
affect the axonal transport of numerous cargos, including late
endosomes, lysosomes, and mitochondria. The following three
CDK5 inhibitors were assessed: a dnCDK5 construct, a chemical
inhibitor (roscovitine), and depletion of endogenous CDK5 by
siRNA. All three failed to affect the processivity, motility, or speed
of bidirectional cargo. While prior work reported that expression
of dnCDK5 induced a complete block in the transport of lyso-
tracker-positive organelles (Pandey and Smith, 2011), these ex-
periments were conducted using a model in which sciatic nerve
crush was performed prior to DRG isolation; this procedure
may affect downstream regulatory mechanisms. As we found
that expression of dnCDK5, depletion of endogenous CDK5, or
chemical inhibition of CDK5 did not significantly affect the
motility of lysosomes in wild-type DRG neurons, we conclude
that CDK5 does not play a significant role in the regulation of
constitutive axonal transport in this model.
Although reduction of CDK5 activity had little effect on axonal
transport in our experiments, increasing CDK5 activity signifi-
cantly altered the dynamics of cargo transport. Expression of
the CDK5 activator p25 increased the likelihood that late endo-
somes/lysosomes or mitochondria would pause or reverse di-
rection during periods of directed motion. Despite the increase
in nonprocessive events, these bidirectional cargos did not
display net changes in speed (Figures S1E and S2A). For lyso-
somes, the increased frequency of non-motile events was
matched by a decrease in the duration of each event (Figures
S1G and S1H). In the context of increased CDK5 activity, pauses
were shorter and directional changes covered less distance
before resuming the initial direction of motion.
Increased CDK5 activity more significantly altered the trans-
port of TrkB-positive signaling endosomes and autophago-
somes; these unidirectional cargos exhibited reductions in
peak speed when CDK5 was aberrantly activated, along with
an increase in nonprocessive events. As retrograde cargos rely
primarily on dynein for motility, we propose that alterations in
the mechanochemistry of dynein more profoundly affect their
speeds. In contrast, bidirectional cargos, such as lysosomesiled-coil domain, and a b-propeller domain that binds to dynein and Ndel1.
1, mutant Ndel1 unphosphorylatable by CDK5, and a Lis1 K147A mutant that
1-RFP.
pression of non-phosphorylatable Ndel1. Vertical stripes indicate transfection
table Ndel1. Only p < 0.0001 are noted.
s pronounced in the setting of the Lis1 K147A mutant.
d retrograde-directed lysosomes while increasing the percentage of stationary
-type construct.
ild-type or mutant Ndel1 and mutant Lis1 are shown.
in the absence of phosphorylatable Ndel1. Vertical stripes indicate transfection
table Ndel1. Only p < 0.0001 are noted.
expressing the Lis1 mutant.
irected autophagosomes while increasing the percentage of stationary auto-
rons from at least three experiments. Values that differ significantly (one-way
post hoc test, G and K) are noted on graphs (*p < 0.05, **p < 0.01, ***p < 0.001);
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Figure 6. SOD1 Mutant Mice Have Deregu-
lated CDK5 Activation Resulting in Trans-
port Disruption, Which Can Be Rescued by
Reducing CDK5 Activity
(A) Western blots of low-speed and high-speed
extracts of spinal cord from SOD1G93A and age-
matched wild-type mice with an antibody recog-
nizing both p35 and p25. Blots also were stained
for b-catenin.
(B) Western blots of spinal cord extracts from
SOD1G93A and wild-type littermate mice with a
phospho-T219-specific antibody to Ndel1. Blots
also were stained for b-catenin.
(C) An increase in p25/p35 ratio was found in high-
speed extracts from SOD1G93A mice as compared
with wild-type littermate mice (means ±SEM; n = 4
mice).
(D) Spinal cords from SOD1G93A mice expressed
higher levels of Ndel1 phosphorylation at CDK5
site T219 than wild-type littermate animals (means
± SEM; n = 6 mice).
(E) Kymographs of TrkB motion in DRG neurites
from 90- to 100-day-old SOD1G93A mice trans-
fected with TrkB-mRFP in the absence and pres-
ence of roscovitine. Representative runs are
highlighted to the right of each kymograph as fol-
lows: green, anterograde; red, retrograde; and
yellow, stationary.
(F) Expression of mutant SOD1 increased non-
processive motion of TrkB cargo. Reducing CDK5
activity in SOD1G93A neurons using roscovitine
rescued the observed effects on transport (mean ±
SEM; nR 18 neurons from three experiments).
(G) Speed of actively transported TrkB cargo
decreased significantly in SOD1G93Amice (means±
SEM; nR 18 neurons from three experiments).
Scale bars represent 10 s and 10 mm. Values that
differ significantly (Student’s t test, C and D, one-
way ANOVA with Tukey’s post hoc test, F and G)
are noted on graphs (*p < 0.05, **p < 0.01, ***p <
0.001).and mitochondria, have both dynein and kinesin motors bound
to them (Fu and Holzbaur, 2014); we hypothesize that the power-
ful kinesin motors bound to these cargos may effectively over-
come the pausing induced by Lis1-bound dynein motors.
In addition to decreasing processive motion of cargo,
increasing CDK5 activity via p25 also increased cargo density
in the mid-axon. This was most notable for mitochondria, which
previously have been determined to undergo fission in the pres-
ence of elevated CDK5 activity (Meuer et al., 2007). Lysosomes,
autophagosomes, and signaling endosomes also exhibited
increased density upon CDK5 activation (Figures S1F and S3),
but no parallel changes in organelle size were observed. It is
possible that the increased density is due to an increase in cargo
trafficking to the axons, as studies in C. elegans have implicated
CDK5 in axonal-dendritic cargo sorting (Goodwin et al., 2012; Ou
et al., 2010). In contrast, reducing CDK5 activity levels did not
alter the density of cargo in the mid-axon for any of the cargos
examined.470 Cell Reports 12, 462–473, July 21, 2015 ª2015 The AuthorsThe generalized response to increased CDK5 activity impli-
cates a common regulatory mechanism. Previous studies identi-
fied Ndel1 as a phosphorylation target of CDK5 (Niethammer
et al., 2000), leading us to hypothesize that CDK5 could affect
transport of a wide range of cargo via the Lis1/Ndel1/
dynein complex. Consistent with this, we found that blocking
the CDK5-dependent phosphorylation of Ndel1 significantly
reduced the p25-induced increase in nonprocessive motility;
expression of a dynein-binding mutant of Lis1 also blocked the
effects of CDK5 activation.
The observations reported here argue that CDK5 is not
involved in the regulation of constitutive axonal transport along
the axon. Instead, our results point to a model in which cellular
stress leads to the spatially and temporally unregulated activa-
tion of CDK and the hyperphosphorylation of Ndel1. This phos-
phorylation frees Ndel1 from auto-inhibition, promoting the for-
mation of a Lis1/Ndel1/dynein complex (Bradshaw et al., 2013;
Zy1kiewicz et al., 2011). This complex acts as a clutch (Huang
Figure 7. Model for the CDK5-Dependent Regulation of Transport
through Ndel1, Lis1, and Dynein
Cargo is actively transported in the retrograde direction by dynein or the
anterograde direction by kinesin. CDK5 is activated in healthy cells by mem-
brane-bound p35 in a spatially and temporally specific manner. (Top) Ndel1,
phosphorylated by activated CDK5, recruits Lis1 to dynein, leading to a sus-
tained interaction of dynein with the microtubule. This causes increased
pausing during transport. (Middle) Dephosphorylation of Ndel1 causes the
Lis1/Ndel1 complex to release from dynein. Dynein pauses less often without
the Lis/Ndel clutch. However, without Lis1 and Ndel1 to hold dynein to the
microtubule, dynein is more likely to disengage when encountering an
obstacle. (Bottom) In the pathologic state, p35 is cleaved into p25, which
causes prolonged and mislocalized activation of CDK5. This, in turn, causes
increased phosphorylation of Ndel1, leading to strong recruitment of Lis1 to
dynein and subsequent disruption of transport.et al., 2012) that interrupts processive motility along the axon
(Figure 7, top). In contrast, dephosphorylated and auto-in-
hibited Ndel1 cannot bind dynein. Without the Lis1/Ndel1 com-
plex bound, dynein processes easily, but is prone to detach
from the microtubule, as the clutch function of Lis1 and
Ndel1 is not available to block dissociation when an obstacle
is encountered (Figure 7, middle; Huang et al., 2012). As this
mechanism is dynein dependent, organelles that primarily
move retrogradely are more strongly affected by changes in
CDK5 levels.
In stressed neurons, both the prolonged activation and the
mislocalization of CDK5 induced by p25 causes Ndel1 to remain
consistently phosphorylated, thus enhancing the formation of
the Lis1/Ndel1/dynein complex and causing an increase in the
frequency of interrupted runs of motion (Figure 7, bottom). As a
result, enhanced phosphorylation of Ndel1 is pathological. Pro-
longing the engagement of dynein with the microtubule through
hyperphosphorylation of Ndel1 also would be likely to transientlystall kinesin-driven transport, as both dynein and kinesin are
bound to most cargos actively transported along the axon (Fu
and Holzbaur, 2014). However, kinesin is more powerful than
dynein and more likely to win a sustained tug-of-war (Hancock,
2014), potentially explaining why cargos with active kinesin mo-
tors exhibit less disruption of motility than what was observed for
predominantly retrograde cargos (Figure S1G).
The disruption of transport induced by CDK5 activation is
reminiscent of previous observations demonstrating enhanced
pausing and switches of cargos moving along axons of neurons
from SOD1G93A mice (Bilsland et al., 2010; Perlson et al., 2009).
Further, both p25 levels and CDK5 activity are known to
be elevated in the SOD1G37R mouse line (Nguyen et al.,
2001). Here we confirmed this observation in the SOD1G93A
model and tested the effects of reducing CDK5 activity. Inhibi-
tion of CDK5 rescued the transport defect observed in neurons
from SOD1G93A mice and corrected the mitochondrial fragmen-
tation phenotype (Figure S5), suggesting that treatment with
CDK5 inhibitors may restore deficits in axonal transport in
affected neurons in ALS. CDK5 inhibitors have been shown to
mitigate neurological damage in stroke models (Menn et al.,
2010); a similar therapy may be of value in the treatment of pa-
tients with ALS.
Taken together, this study highlights the differences in CDK5-
dependent regulation of transport between healthy and stressed
neurons. In healthy cells, CDK5 has minimal effect on cargo
transport. However, when hyperactivated by p25, mislocalized
CDK5 disrupts transport by increasing the number of nonpro-
cessive events for cargos including lysosomes, mitochondria,
autophagosomes, and signaling endosomes. Further, we iden-
tify a Lis1/Ndel1-dependent mechanism by which pathological
activation of CDK5 leads to the misregulation of axonal trans-
port. As elevated CDK5 levels seen in neurons from multiple
disease models correlate with defects in axonal transport, these
transport defects potentially may be ameliorated by therapeutics
targeted to modulation of CDK5 activation.
EXPERIMENTAL PROCEDURES
Reagents, extraction of spinal cord lysates, and CDK5 depletion are described
in detail in the Supplemental Experimental Procedures.
Live-Cell Imaging
DRG neurons were isolated from mice according to Perlson et al. (2009); all
animal protocols received prior approval from the University of Pennsylvania
Institutional Animal Care and Use Committee. Neurons were maintained in
F-12 media (Invitrogen) with 10% heat-inactivated fetal bovine serum,
2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. For
live-cell analysis, DRG neurons were plated on glass-bottom dishes (World
Precision Instruments) and cultured for 2 days at 37C in a 5% CO2 incu-
bator. Before plating, neurons were transfected with 0.5–0.7 mg plasmid
DNA or 20–60 pM siRNA as noted, using a Nucleofector (Lonza) according
to the manufacturer’s specifications. Then 20 mM roscovitine (Cell Signaling
Technology) or DMSO was added as noted 24 hr prior to imaging. Imaging
was performed in low-fluorescence nutrient medium (Hibernate A, BrainBits)
with 2% B27 and 2 mM GlutaMAX on an inverted epifluorescence micro-
scope (DMI6000B, Leica Camera AG) using an Apochromat 633, 1.4 NA
oil immersion objective (Leica Camera AG) in an environmental chamber at
37C. Digital images were acquired with an ORCA-R2 (Hamamatsu) using
LAS-AF software (Leica Camera AG). Images were taken every 3 s for a total
of 3 min for GFP-LC3 and DsRed2-mito, every 368 ms for a total of 1.06 minCell Reports 12, 462–473, July 21, 2015 ª2015 The Authors 471
for GFP-Rab7 and LAMP1-RFP, and every 500 ms for a total of 2 min for
mRFP-TrkB.
Image Analysis
Kymographs were generated using MetaMorph. Only healthy neurons were
included, as defined by displaying >10% motile puncta (traveling a net dis-
tance of R10 mm) for LAMP1-RFP, GFP-Rab7, and mRFP-TrkB or >5%
motile DsRed2-mito puncta. An exception was made for neurons expressing
Lis1 K147A, where R5% motility of LAMP1-RFP puncta was required for in-
clusion. The total number of vesicles was determined and normalized by
kymograph length; mitochondrial size was determined by line scan. Fluores-
cent puncta were tracked from the beginning to the end of the kymograph to
characterize motion as anterograde (R10 mm), retrograde (R10 mm), or non-
motile (<10 mm). To focus specifically on the interruption of highly processive
motility, three puncta per kymograph that traveled the farthest distance over
the imaging sequence, in either the anterograde or retrograde direction, were
tracked manually using ImageJ and assessed for total run length, run time,
and number of pauses and reversals. A pause was defined as single or
consecutive instantaneous velocities of <0.067 mm/s, the resolution of our
system. A reversal was defined as a displacement of R1.5 mm in the direc-
tion opposite to net cargo displacement. Peak speed was determined using
the fastest three anterograde and retrograde cargo per kymograph.
Ensemble speed was determined using all available vesicles, stationary or
moving. All movies were recorded in the mid-axon, >70 mm from both the
axon tip and cell body.
TIRF Assay for Microtubule Binding
HeLa cells expressing GFP-DHC (Kiyomitsu and Cheeseman, 2012)
(A. Hyman, Max Planck Institute) were transiently transfected with Fugene 6
(Roche) and harvested 20–24 hr post-transfection. For microtubule binding
assays, transfected HeLa cells were lysed in 40 mM HEPES, 1 mM EDTA,
120 mM NaCl, 0.1% Triton X-100, and 1 mM MgATP supplemented with
protease inhibitors (1 mM PMSF, 0.01 mg/ml TAME, 0.01 mg/ml leupeptin,
and 0.001 mg/ml pepstatin-A). Lysates were clarified by centrifugation at
1,0003 g and then at 100,0003 g. Clarified lysates were diluted in P12 buffer
(12 mM PIPES, 1 mM EGTA, and 2 mM MgCl2 [pH 6.8]) immediately before
perfusion into the flow chamber. For a 70%–80% confluent 10-cm plate,
cells were lysed in 100 ml lysis buffer, which was then diluted 1:20 or 1:50
for single-molecule imaging. Anti-tubulin antibody (Sigma-Aldrich) was incu-
bated in flow chambers constructed as described previously (Ayloo et al.,
2014) for 5 min, followed by blocking with 5% pluronic F-127 (Sigma-Aldrich)
for 5 min. Rhodamine-labeled taxol-stabilized microtubules were flowed into
the chamber and bound to the anti-tubulin antibody for 10 min. Cell lysates
were flowed into the chamber with 10 U/ml hexokinase and 10 mg/ml glucose
to scavenge ATP, along with 1 mg/ml BSA, 1 mg/ml casein, 20 mM taxol,
1 mM DTT, and an oxygen-scavenging system (Schroeder et al., 2010).
After an initial round of imaging of five locations per chamber, 11 ml wash con-
taining 10 mM MgATP was flowed into the chamber, and each location was
re-imaged.
Images were acquired at room temperature using a Nikon TIRF system
(PerkinElmer) on an inverted Ti microscope with a 1003 objective and an
ImagEM C9100-13 camera (Hamamatsu) with Volocity software. Microtu-
bules were randomly chosen from the TIRF field for analysis. GFP fluores-
cence along the microtubules was measured by line scan using FIJI and
corrected for background fluorescence along a line of approximately equal
length in the vicinity of the microtubule. Intensity values at least 10%
above background were scored to measure the length of the microtubule
occupied. Maximum-intensity projections were normalized to the length of
the microtubule.
Microtubule co-sedimentation assays were performed on transfected DHC-
GFPHeLacells thatwere harvested in 80mMPIPES, 1mMEGTA, 1mMMgCl2,
and 0.5% Triton X-100 with protease inhibitors. Lysates were centrifuged at
1,000 3 g and then at 100,000 3 g. The clarified lysates were combined with
5 mM taxol-stabilized microtubules and/or 10 mM MgATP and incubated at
37C prior to centrifugation at 39,0003 g to pellet the microtubules and bound
proteins. Supernatant and pellet fractions were resuspended in denaturing
buffer and boiled prior to analysis by SDS-PAGE and western blot.472 Cell Reports 12, 462–473, July 21, 2015 ª2015 The AuthorsSUPPLEMENTAL INFORMATION
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